IBM's Two-Pronged Play: Selling Control in an AI Wild West While Protecting the Mainframe Fortress
18.06.2026 - 16:15:11 | boerse-global.de
The technology industry has a dirty secret, and Big Blue is betting heavily that cleaning it up will be a lucrative business. A new study from IBM's own research arm has laid bare a systemic failure: companies are deploying artificial intelligence so recklessly that most have already lost the ability to manage it. The gap between the hype and the reality of control is widening by the day, and IBM is rushing to fill it with a suite of products and partnerships that span from the boardroom to the mainframe floor.
Seventy percent of technology managers surveyed by the IBM Institute for Business Value admitted their organizations are rolling out AI systems faster than their own IT departments can track them. The study, published on June 17, paints a grim picture of chaos masked by excitement. Vendor lock-in is already entrenched: 71% of organizations say they would struggle to switch their primary AI provider. Even more alarming, 81% of executives reported that a one-week outage of their AI systems would effectively shut down their operations. IBM dubs this the "sovereignty trap" — and positions itself as the only escape route.
The immediate answer is a new product from IBM's Apptio subsidiary, launched this week under the name "Conversational Insights." It embeds watsonx.ai into hybrid IT cost-management software, translating technology spending into measurable business outcomes. The timing is no coincidence. According to the same study, 90% of corporate leaders doubt the return on investment of their AI projects. Apptio's tool is designed to plug that accountability gap — turning the chaos of AI spending into a controllable ledger.
But control isn't just about costs. It is also about security, especially on the mainframes that still underpin much of the global financial system. That is where another new product comes in. On Friday, IBM launches the "zSecure Secret Manager," a piece of software that automates the management of security certificates on its Z-series mainframes. Manual processes are being replaced to reduce administrative burdens and prevent system failures. Banks and government agencies, where mainframes serve as the first line of defense, are the primary targets for this upgrade.
Should investors sell immediately? Or is it worth buying IBM?
The mainframe security push is paired with a broader software offensive. IBM and ServiceNow are deepening their alliance to break open legacy enterprise data and make it usable for AI workloads. Starting in the second half of 2026, customers will gain new tools that allow them to run IBM software directly from the ServiceNow platform. The partnership integrates Red Hat Ansible and HashiCorp into existing IT workflows, while IBM watsonx.data will monitor data quality. This is a long-term bet on interoperability as the key to AI adoption in complex, regulated environments.
Meanwhile, IBM is planting a flag in the distant future of computing. The company cut the ribbon on a Quantum and AI Innovation Center in Amaravati, India, with plans to build a large team focused on practical quantum solutions for healthcare and logistics. Far removed from the daily stock volatility that has rattled the shares recently, this is a patient investment in a technology that may take years to mature.
The market has responded to this strategic reshaping with mixed signals. The stock closed at €230.35 on Thursday, up about 1% on the day as a tentative recovery from the pressure that the Federal Reserve's hawkish stance has applied to the entire tech sector. A day earlier, the shares had settled at €228.00, more than 22% below the record high hit at the beginning of the month. On a 30-day basis, however, the stock has still rallied over 20% — a sign that investors are betting on the new narrative. Yet year-to-date the shares remain roughly 7% in the red, with the 52-week high of €292.85 from June sitting 21% above the current price.
Technical indicators suggest a market in wait-and-see mode. The 200-day moving average sits at €235.67, just above Thursday's close, forming the next resistance zone. The relative strength index has settled at a neutral 50.1, down from overbought levels two weeks ago. The annualized 30-day volatility now exceeds 66% — a reminder that IBM is no longer a sleepy blue chip but is being treated as an AI and quantum growth name, with all the turbulence that entails.
Wall Street analysts are cautiously optimistic about the transformation. Bank of America recently raised its price target to $315 per share, with analyst Wamsà Mohan citing sustained demand for AI infrastructure in a reiterated buy rating. The consensus target among analysts stands at €251.07 a share, implying about 9% upside from current levels. Fundamental support comes from the first quarter: revenue rose to $15.9 billion, with the infrastructure segment growing 12% year-on-year. Free cash flow hit $2.2 billion, its highest level in a decade.
IBM at a turning point? This analysis reveals what investors need to know now.
Still, the stock's valuation is historically stretched, leaving little room for disappointment. If support at the 50-day moving average near €215 fails, a deeper sell-off could follow. The bearish case rests on that exact point: that IBM's narrative of control and governance is compelling in theory, but the price already reflects high expectations.
The crux of the bet is simple. IBM is wagering that enterprises will pay a premium to regain oversight of their AI infrastructure — that the cost of chaos will exceed the price of a ticket back to order. After a decade of transformation, the company is finally selling something the whole industry desperately needs: a way to put the AI genie back in its bottle.
Ad
IBM Stock: New Analysis - 18 June
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
